Aurobindo, Torrent Infringe Sanofi's Uroxatral IP: Judge

Law360, New York (August 19, 2010, 2:17 PM EDT) -- A federal judge has ruled that Sanofi-Aventis’ patent covering prostate treatment Uroxatral is valid and infringed by proposed generic versions from Aurobindo Pharma Ltd. and Torrent Pharma Inc.

Judge Gregory M. Sleet of the U.S. District Court for the District of Delaware issued the decision Tuesday, basing it on an earlier ruling in favor of Sanofi in its fight against Mylan Pharmaceuticals Inc. over a copycat version of the drug.

Sanofi launched patent infringement suits against Aurobindo Pharma, Aurobindo Pharma USA Inc., Torrent Pharma, Torrent Pharmaceuticals...
To view the full article, register now.